Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. a single-blind, randomized, controlled, crossover trial

HIGHLIGHTS

• who: Emilie Bundgaard Lindkvist and collaborators from the Riuniti, Italy Oregon Health and Science University have published the research work: Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial, in the Journal: (JOURNAL)
• what: The aim of this study was therefore to test the hypothesis , that the updated DiaCon AP DH configuration would be safe and effective to use in individuals with T1D between 13-17 years old and that it would be superior in managing glycemia . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.